Controversial and changing trends in blood transfusion

Area of Science:

• Transfusion Medicine
• Hematology
• Blood Banking

Background:

• Component therapy has become widely available due to advancements in blood and plasma donation, cell separation, preservation, and plasma fractionation.
• The increased availability of blood products has broadened discussions on the use and potential misuse of whole blood and its components.
• Clinical use of blood products presents ongoing challenges within advanced transfusion services.

Purpose of the Study:

• To critically review current controversial and evolving trends in the clinical application of cell concentrates.
• To provide insights into the changing landscape of transfusion practices related to cellular blood products.
• To address specific issues arising from the clinical use of blood products.

Main Methods:

• Literature review focusing on recent advancements and controversies in cell concentrate utilization.
• Analysis of trends in component therapy and transfusion medicine.
• Synthesis of information on the clinical use of blood products.

Main Results:

• Identification of key areas of controversy in the use of cell concentrates.
• Documentation of shifting trends in transfusion practices for cellular products.
• Highlighting challenges associated with the clinical application of blood components.

Conclusions:

• The field of transfusion medicine is dynamic, with ongoing debates surrounding the optimal use of cell concentrates.
• Continuous evaluation of transfusion practices is necessary to address emerging challenges and controversies.
• Further research and guideline development are needed to navigate the evolving trends in cell concentrate therapy.